|
Comparative safety and cost effective analysis between aceclofenac, lornoxicam and diclofenac in patients of musculo skeletal disorder |
Patnaik KP, Das P, Hota S, Mohapatra BN, Mohapatra S, Nayak S, Panigrahi S |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Patnaik KP, Das P, Hota S, Mohapatra BN, Mohapatra S, Nayak S, Panigrahi S. Comparative safety and cost effective analysis between aceclofenac, lornoxicam and diclofenac in patients of musculo skeletal disorder. International Journal of Pharmaceutical Sciences and Research 2012; 3(9): 3407-3411 Indexing Status Subject indexing assigned by CRD MeSH Anti-Inflammatory Agents, Non-Steroidal; Cost-Benefit Analysis; Diclofenac; Drug Toxicity; Humans; Musculoskeletal Diseases; Piroxicam AccessionNumber 22013019118 Date bibliographic record published 10/06/2013 |
|
|
|